Ecospray Chooses relayr to Revolutionize the Maritime Industry With Artificial Intelligence Powered Solutions
18.2.2021 15:54:00 EET | Business Wire | Press release
Ecospray, a company specializing in the research and development of cutting-edge systems for controlling air and gas emissions in industrial applications for the Maritime industry, has chosen relayr, a leading industrial IoT company based in Berlin, to create new IoT-based desulphurization solutions, driving the sector towards an increasingly digital, efficient and environmentally sustainable future.
The Maritime Industry has been one of the latest in addressing the need to reduce its environmental impact. Now, with the introduction of IMO regulations aimed at reducing sulphur oxide emissions - which came into force in January 2020 - the industry is facing a rising pressure to comply with more stringent environmental regulations, as well as the need of containing costs and improve efficiency in an increasingly competitive and unpredictable market.
In this context, fleets can resort to various solutions, including the installation of scrubbers to remove SOx emissions, or using alternative fuels such as very-low-sulphur fuel oil (VLSFO) but with significantly higher costs compared to bunker fuel.
To meet these market challenges while aiming at developing new solutions capable of radically renewing the entire maritime transport sector, Ecospray has chosen to collaborate with relayr , a company specializing in IoT solutions oriented for business outcomes. The partnership between the two companies will allow the creation of a new generation of emission control equipment: smart scrubbers managed using artificial intelligence, a completely new solution for the market.
Ecospray, market leader in marine emission purification systems (EGCS), has always been committed to developing technological solutions for the maritime sector that can make the processes of reducing the pollutants in the gases produced by ships more efficient. The integrated technologies offered by Ecospray aim at reducing emissions and saving fuel, leading ship owners on the path towards decarbonization of the sector and encouraging the use of clean energy. Part of Carnival Group since 2013, the Italian company has continued to grow in recent years by increasingly specializing in offerings for the marine segment.
"Being part of Carnival Corporation has given us the opportunity to implement high-performance and reliable technological solutions in record time. We were enabled to gain experience across the entire fleet and unparalleled sailing experience, which has allowed us to build robust and use case specific innovations at speed," said Stefano Di Santo, CEO of Ecospray.
The new IMO-compliant devices are not only an innovation that drives an environmentally intensive industry towards a more sustainable future but also an investment that will significantly reduce equipment-running costs for shipbuilders.
The integration of relayr’s IIoT and AI offering tailored to the devices allows to guarantee constant compliance with IMO regulations for the containment of air pollution in the maritime environment. Moreover, it allows significant savings in terms of performance and maintenance through remote monitoring and advanced life cycle analysis. The ability to constantly monitor and analyze the scrubbers’ performance ensures longer equipment life and fuel savings by optimizing pumping operations while also allowing a significant reduction in operating costs.
"We are delighted to collaborate with a company like Ecospray, igniting together the digital transformation of the marine industry," says Josef Brunner, CEO of relayr. "This partnership allows us to enter a new market – bringing high added value with IIoT solutions, helping to exploit the full potential of the control systems machines, and ultimately contributing to the reduction of harmful gas emissions."
“In the maritime industry, a fleet could include hundreds of ships, so the opportunities to build smart machines on such a large scale are literally endless," commented Stefano Di Santo, CEO of Ecospray. "The partnership with relayr allows us to confidently face the challenge of bringing the best of 4.0 technologies to the naval sector. The constant motivation that this project offers us on a daily basis requires a totally different and creative approach to problem solving. I am certain of one thing: together we will never stop improving. Ecospray and relayr: disrupting innovations across the oceans."
The process of digitalization of equipment for gas emission control is only a first step towards a broader business transformation process for the Alessandria-based Ecospray. The visionary approach in collaboration with relayr ultimately envisages the adoption of the Equipment as a Service (EaaS) model. Unlike the traditional asset purchase model, EaaS is based on a pay-per-use offering, in which equipment is no longer purchased but provided in exchange for a usage fee.
Thanks to relayr's experience in implementing the EaaS model, Ecospray will be able to create even more value for its customers, diversifying its revenue streams by offering new services and emerging in the current market scenario.
About Ecospray
From research to development, Ecospray Technologies is specialized in integrated solutions for the green conversion of the maritime and land industries as well as the reduction of dependency on fossil fuels. Founded in 2005 and part of Carnival Group since 2013, Ecospray operates at global level, offering systems aimed at making industrial processes more sustainable through the purification and treatment of pollutants, from emission removal to fuel saving and water filtration. Ecospray's technological solutions leverage three distinctive factors – technology delivered as a service, analysis and use of relevant data, and finance – to facilitate access to innovation and significantly advance the energy transition towards decarbonization and the creation of clean energy.
About relayr
Relayr is the Industrial Internet of Things (IIoT) powerhouse delivering the most complete solutions for risk-free digital transformations. We unleash data insights from existing equipment, machines and production lines to improve our customers’ business outcomes. We enable industrial companies to shift from CAPEX to OPEX-based offerings on their respective markets, providing a unique combination of first-class IIoT technology and its delivery with powerful financial and insurance offerings – all from a single source trusted by hundreds of companies worldwide. With relayr, manufacturers, operators, and service companies for industrial equipment are empowered to implement fully interoperable IIoT solutions guaranteed to achieve their target business outcomes.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005584/en/
Contact information
Ecospray
Eleonora Castiglione
Marketing & Communications Manager
castiglione@ecospray.eu
relayr
David Petrikat
Senior Vice President Marketing & Portfolio
david.petrikat@relayr.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
